Despite these findings, BCG vaccination was associated with a stronger cytokine (specifically, interleukin 6 [IL-6]) response following ex vivo stimulation of peripheral blood mononuclear cells in patients with no known history of COVID-19 (42). The gene discussed is IL6; the disease is COVID-19.